EP 4157323 A1 20230405 - A COMPOSITION COMPRISING HP-HMG FOR USE IN TREATING INFERTILITY
Title (en)
A COMPOSITION COMPRISING HP-HMG FOR USE IN TREATING INFERTILITY
Title (de)
ZUSAMMENSETZUNG MIT HP-HMG ZUR VERWENDUNG BEI DER BEHANDLUNG VON UNFRUCHTBARKEIT
Title (fr)
COMPOSITION COMPRENANT HP-HMG POUR UNE UTILISATION DANS LE TRAITEMENT DE L'INFERTILITÉ
Publication
Application
Priority
- US 202063032430 P 20200529
- EP 20182800 A 20200629
- EP 2021064376 W 20210528
Abstract (en)
[origin: WO2021239961A1] The present invention relates to improved assisted reproductive technology for women predicted to have a high ovarian response to controlled ovarian stimulation that comprise targeting a threshold serum hCG level by the final day of stimulation.
IPC 8 full level
A61K 38/24 (2006.01); A61P 15/08 (2006.01)
CPC (source: EP IL KR US)
A61B 17/435 (2013.01 - US); A61K 38/24 (2013.01 - EP IL KR US); A61P 15/08 (2018.01 - KR US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021239961 A1 20211202; AU 2021281055 A1 20230119; BR 112022023176 A2 20230110; CA 3182102 A1 20211202; CL 2022003372 A1 20230804; CN 115803046 A 20230314; CO 2022017203 A2 20221209; EP 4157323 A1 20230405; IL 298550 A 20230101; JP 2023527221 A 20230627; KR 20230018428 A 20230207; MX 2022015031 A 20230104; TW 202210096 A 20220316; US 2023210955 A1 20230706
DOCDB simple family (application)
EP 2021064376 W 20210528; AU 2021281055 A 20210528; BR 112022023176 A 20210528; CA 3182102 A 20210528; CL 2022003372 A 20221129; CN 202180036084 A 20210528; CO 2022017203 A 20221130; EP 21727190 A 20210528; IL 29855022 A 20221124; JP 2022573348 A 20210528; KR 20227045416 A 20210528; MX 2022015031 A 20210528; TW 110118525 A 20210521; US 202117928176 A 20210528